Ra Medical Systems, Inc. (RMED)

Last Price: 7.20 (2021-01-20)

Company Description

Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter system used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or above- and below-the-knee. Pharos Excimer Laser is a powerful 308 nm ultraviolet-B excimer laser used by physicians as a tool to treat chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis and leukoderma. Ra Medical Systems, Inc. is based in Carlsbad, California.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $7.20M
Net Income (Most Recent Fiscal Year) $-56.96M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 4.44
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.66
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -771.89%
Net Margin (Trailing 12 Months) -772.04%
Return on Equity (Trailing 12 Months) -120.68%
Return on Assets (Trailing 12 Months) -85.93%
Current Ratio (Most Recent Fiscal Quarter) 4.62
Quick Ratio (Most Recent Fiscal Quarter) 4.30
Debt to Common Equity (Most Recent Fiscal Quarter) 0.06
Inventory Turnover (Trailing 12 Months) 2.18
Book Value per Share (Most Recent Fiscal Quarter) $61.81
Earnings per Share (Most Recent Fiscal Quarter) $-3.25
Earnings per Share (Most Recent Fiscal Year) $-108.25
Diluted Earnings per Share (Trailing 12 Months) $-46.00
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Common Shares Outstanding 2.92M
Free Float 2.85M
Market Capitalization $20.35M
Average Volume (Last 20 Days) 0.26M
Beta (Past 60 Months) 1.62
Percentage Held By Insiders (Latest Annual Proxy Report) 2.40%
Percentage Held By Institutions (Latest 13F Reports) --
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%